Social Media Ideas for Translational Medicine

<![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

Transcripta Bio Announces Research Collaboration to Advance Discovery of New ALS Treatments

Transcripta Bio and Mayo Clinic will combine single-cell RNA sequencing with AI-driven analysis of patient-derived ALS tissue to identify disease signatures and potential therapeut...

Rewriting the rules of genetic medicine with tRNA therapeutics

Our guest today is Dr. Nerissa Kreher, Chief Medical Officer of Alltrna. Nerissa brings two decades of rare disease drug development experience. The post Rewriting the rules of gen...

Particle Engineering Takes Center Stage as Pharmaceutical Formulation Science Pushes Toward Translational Breakthroughs

The Journal of Pharmaceutical Investigation has announced a January 2027 special issue on translational advances in pharmaceutical dosage form development, with submissions due by...

The Epitranscriptome Heads Toward Clinical Necessity

Short-read RNA sequencing reporting the modifications that alter protein output is starting to make epitranscriptomics indispensable for patient selection in precision medicines. T...

<![CDATA[The Future of Precision Medicine Depends on More Than Biology]]>

Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis

It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.  The post Precision Medicine Transformed...

Inhaled Suppressor tRNA Restores Gene Function in Cystic Fibrosis Models

A preclinical study showed how chemically enhanced suppressor tRNAs combined with a lung-targeted delivery system can restore production of a critical protein in models of cystic f...

From Discovery to Development

The articles in this eBook examine key trends driving this transformation, from AI-enabled discovery and experimental validation to advanced cell, gene, and biologic platforms, and...

Precision for All: Closing the gap between innovation and impact

Why diagnostic-driven therapies need a new commercialization model to reach more eligible patients.

A New RNA Strategy Could Target Thousands of Genetic Disorders

This new approach targets disorders including cystic fibrosis, muscular dystrophy, and some cancers. In lab-grown tissue from a cystic fibrosis patient who did not respond to exist...

Bridging the Translational Gap in Pancreatic Cancer Through Biology-First Modeling

In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to understand patient tumor states and next-generation precli...

<![CDATA[MRD Testing Is Becoming the Most Important Tool in Oncology Drug Development: Q&A with Eric Matthews]]&g...

Advancing Brain Organoids from Research Models to Scalable Platforms

In this GEN webinar, Joseph Shultz (VP of technical development and manufacturing, Ottimo Pharma) and Imroz Ghangas (VP of commercial sales, Asimov) discuss strategies for achievin...

Transcenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology

Transcenta, headquartered in China and with a pipeline of over ten therapeutic antibody candidates, is a clinical-stage biopharmaceutical company with expertise in biologics discov...

<![CDATA[From Direct-to-Patient to Direct-to-Disease: New Commercialization Models in Europe]]>

<![CDATA[The Next Chapter in Metabolic Drug Development]]>

Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Ca...

Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancersManagement to discu...

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models

The collaboration pairs the Genialis Supermodel with Inventia Life Science’s RASTRUM 3D cell model platform to test therapeutic hypotheses in models that mirror the tumor biology o...

<![CDATA[From a Medical Content Pipeline to a Medical Content Loop]]>

Transcriptomic Approaches to Guiding the Discovery of Geroprotective Compounds

A great deal of drug discovery starts by screening compounds from the vast libraries of molecules that exist. The libraries are too large to screen everything (and even then the sc...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult provided its investment and expert support to help two biotech companies accelerate the development of new treatments for a range of autoimmune, inflam...

Targeted Reduction of PTBP1 Reverses Cognitive Impairment in a Mouse Model of Alzheimer's Disease

Many of the more sophisticated forms of medicine, including gene therapies and immunotherapies, are challenging to deliver to the brain. At the very least there are far fewer pract...